Form 8-K - Current report:
SEC Accession No. 0001144204-17-011793
Filing Date
2017-02-28
Accepted
2017-02-28 17:04:42
Documents
27
Period of Report
2017-02-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v460687_8k.htm 8-K 17483
2 EXHIBIT 99.1 v460687_ex99-1.htm EX-99.1 27253
3 GRAPHIC image_001.jpg GRAPHIC 376416
4 GRAPHIC image_002.jpg GRAPHIC 244522
5 GRAPHIC image_003.jpg GRAPHIC 164635
6 GRAPHIC image_004.jpg GRAPHIC 284772
7 GRAPHIC image_005.jpg GRAPHIC 170644
8 GRAPHIC image_006.jpg GRAPHIC 159515
9 GRAPHIC image_007.jpg GRAPHIC 133323
10 GRAPHIC image_008.jpg GRAPHIC 153837
11 GRAPHIC image_009.jpg GRAPHIC 121136
12 GRAPHIC image_010.jpg GRAPHIC 137702
13 GRAPHIC image_011.jpg GRAPHIC 368903
14 GRAPHIC image_012.jpg GRAPHIC 340077
15 GRAPHIC image_013.jpg GRAPHIC 187392
16 GRAPHIC image_014.jpg GRAPHIC 159543
17 GRAPHIC image_015.jpg GRAPHIC 143807
18 GRAPHIC image_016.jpg GRAPHIC 180341
19 GRAPHIC image_017.jpg GRAPHIC 167433
20 GRAPHIC image_018.jpg GRAPHIC 161622
21 GRAPHIC image_019.jpg GRAPHIC 183696
22 GRAPHIC image_020.jpg GRAPHIC 167129
23 GRAPHIC image_021.jpg GRAPHIC 119720
24 GRAPHIC image_022.jpg GRAPHIC 338758
25 GRAPHIC image_023.jpg GRAPHIC 166740
26 GRAPHIC image_024.jpg GRAPHIC 142327
27 GRAPHIC image_025.jpg GRAPHIC 284973
  Complete submission text file 0001144204-17-011793.txt   7017049
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 17648916
SIC: 2834 Pharmaceutical Preparations